Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports enhanced metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for optimizing lead compounds due to the electron-withdrawing effects of fluorine atoms, which improve pharmacokinetic properties. Also utilized in the preparation of protease inhibitors and receptor modulators in research settings.